Health Care & Life Sciences » Biotechnology | Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc. | Cash Flow

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
14,886.50
7,833.70
2,843.00
5,026.10
5,030.60
Depreciation, Depletion & Amortization
124.80
146.90
159.50
149.60
179.30
Other Funds
1.60
-
-
-
-
Funds from Operations
2,495.60
4,153.50
3,894.00
4,482.00
4,897.80
Changes in Working Capital
429.40
193.10
518.40
23.60
198.20
Net Operating Cash Flow
2,925.00
3,960.40
4,412.40
4,505.60
4,699.60
Capital Expenditures
9.50
259.00
274.60
402.30
302.70
Sale of Fixed Assets & Businesses
-
2.00
-
-
-
Purchase/Sale of Investments
-
431.20
397.10
959.70
1,994.40
Net Investing Cash Flow
9.50
688.20
122.50
557.40
1,691.70
Net Financing Cash Flow
9,730.80
10,013.60
106.80
7,313.00
-
Net Change in Cash
6,860.90
5,167.90
4,813.00
3,461.40
2,846.00
Free Cash Flow
2,934.50
4,219.50
4,687.00
4,907.90
5,002.40
Change in Capital Stock
9,729.20
10,013.60
106.80
7,313.00
-
Exchange Rate Effect
64.60
197.10
629.80
96.60
162.00

About Stellar Biotechnologies

View Profile
Address
332 East Scott Street
Port Hueneme California 93041
United States
Employees -
Website http://www.stellarbiotechnologies.com
Updated 09/14/2018
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.